The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis.

[1]  F. Breedveld,et al.  Rheumatoid factor production by mononuclear cells derived from different sites of patients with rheumatoid arthritis , 1993, Clinical and experimental immunology.

[2]  T. Sawai,et al.  Stromelysin synthesizing cells in the synovial tissues of rheumatoid arthritis demonstrated by in situ hybridization and immunohistochemical methods. , 1990, The Tohoku journal of experimental medicine.

[3]  D. Willoughby,et al.  Destruction of articular cartilage by alpha2macroglobulin elastase complexes: role in rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[4]  S. Onodera,et al.  Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis* , 2000, The Journal of Biological Chemistry.

[5]  F. Breedveld,et al.  T Cells Cloned from Human Rheumatoid Synovial Membrane Functionally Represent the Th 1 Subset , 1992, Scandinavian Journal of Immunology.

[6]  J. Frölich,et al.  Nitric oxide and inflammatory joint diseases. , 1998, British journal of rheumatology.

[7]  J. Gamble,et al.  Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[8]  D. Woolley,et al.  Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. , 1995, Annals of the rheumatic diseases.

[9]  G. Bilbe,et al.  Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. , 1995, Biochemical and biophysical research communications.

[10]  D. Woolley,et al.  Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. , 1998, British journal of rheumatology.

[11]  J. Woody,et al.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.

[12]  T. Sumida,et al.  Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. , 1997, Arthritis and rheumatism.

[13]  B. Bresnihan,et al.  Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[14]  R. Duthie,et al.  Bone resorption by cells isolated from rheumatoid synovium. , 1992, Annals of the rheumatic diseases.

[15]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[16]  K. Tomita,et al.  Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.

[17]  R. Butler,et al.  Localisation of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis. , 1993, Annals of the rheumatic diseases.

[18]  G. Firestein,et al.  Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. , 1992, The American journal of pathology.

[19]  C. Dinarello.  IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. , 1999, The Journal of allergy and clinical immunology.

[20]  F. Breedveld,et al.  The effects of interferon-β treatment on synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis , 2000 .

[21]  J. Mort,et al.  Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[22]  J Bondeson,et al.  Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Panayi,et al.  Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. , 1993, Annals of the rheumatic diseases.

[24]  C. Berek,et al.  Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Firestein,et al.  How important are T cells in chronic rheumatoid synovitis? , 1990, Arthritis and rheumatism.

[26]  B. Bresnihan,et al.  The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. , 2001, Rheumatology.

[27]  J. Weidner,et al.  Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients , 1996, The Journal of experimental medicine.

[28]  J. Symons,et al.  In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. , 1992, Clinical immunology and immunopathology.

[29]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[30]  J. V. van Meurs,et al.  Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction. , 1999, Journal of immunology.

[31]  R. Gay,et al.  Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[32]  M. Feldmann,et al.  Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[33]  P. Duray,et al.  Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis. , 2000, The Journal of rheumatology.

[34]  T. Thornhill,et al.  Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. , 1998, The American journal of pathology.

[35]  R. Maki,et al.  Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.

[36]  J. Kriegsmann,et al.  Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. , 1995, Arthritis and rheumatism.

[37]  D. Howell,et al.  Interleukin‐1α and β in Growth Plate Cartilage Are Regulated by Vitamin D Metabolites In Vivo , 1997 .

[38]  G. Firestein,et al.  Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. , 1991, Arthritis and rheumatism.

[39]  D. Walsh,et al.  Angiogenesis and arthritis. , 1999, Rheumatology.

[40]  G. Panayi,et al.  Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. , 1994, Annals of the rheumatic diseases.

[41]  K. Miyazaki,et al.  Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with ”multi-labelling subtraction immunostaining” , 1998, Virchows Archiv.

[42]  F. Breedveld,et al.  The effects of interferon beta treatment on arthritis. , 1999, Rheumatology.

[43]  Ian G. Charles,et al.  Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Okamura,et al.  Interleukin-18: a novel cytokine that augments both innate and acquired immunity. , 1998, Advances in immunology.

[45]  A. Manning,et al.  AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. , 1998, Autoimmunity.

[46]  J. Edmonds,et al.  Intraarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis. , 1999, The Journal of rheumatology.

[47]  J. Dayer,et al.  Interleukin-18, rheumatoid arthritis, and tissue destruction. , 1999, The Journal of clinical investigation.

[48]  H. Diamond,et al.  Interleukin-1beta-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. , 1997, Arthritis and rheumatism.

[49]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[50]  Y. Sun,et al.  p53 Down-regulates Human Matrix Metalloproteinase-1 (Collagenase-1) Gene Expression* , 1999, The Journal of Biological Chemistry.

[51]  S S McCachren,et al.  Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. , 1991, Arthritis and rheumatism.

[52]  M. Feldmann,et al.  Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. , 1992, British journal of rheumatology.

[53]  S. Yamashita,et al.  Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. , 1996, Annals of the rheumatic diseases.

[54]  M. Feldmann,et al.  Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. , 1998, Arthritis and rheumatism.

[55]  G. Murrell,et al.  Nitric oxide activates metalloprotease enzymes in articular cartilage. , 1995, Biochemical and biophysical research communications.

[56]  S. Goldring,et al.  Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. , 2000, Arthritis and rheumatism.

[57]  T. Kipps,et al.  Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[58]  I. McInnes,et al.  A proinflammatory role for IL-18 in rheumatoid arthritis. , 1999, The Journal of clinical investigation.

[59]  K. Shiozawa,et al.  Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus. , 1983, Arthritis and rheumatism.

[60]  G. Firestein,et al.  Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. , 1996, The American journal of pathology.

[61]  T. Nakajima,et al.  Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. , 1995, Arthritis and rheumatism.

[62]  G. Janossy,et al.  An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. , 1982, Clinical and experimental immunology.

[63]  U. Müller-Ladner,et al.  Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[64]  D. Woolley,et al.  Histopathology of the rheumatoid lesion , 1984 .

[65]  F. Breedveld,et al.  INCREASED EXPRESSION OF IL‐15 IN THE SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED WITH PATIENTS WITH YERSINIA‐INDUCED ARTHRITIS AND OSTEOARTHRITIS , 1997, The Journal of pathology.

[66]  F. Breedveld,et al.  Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis , 1998, The Journal of pathology.

[67]  E. Tindall,et al.  Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.

[68]  P. Petrow,et al.  Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[69]  D. Woolley,et al.  Mast cells at sites of cartilage erosion in the rheumatoid joint. , 1984, Annals of the rheumatic diseases.

[70]  F. Breedveld,et al.  Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy. , 1998, Arthritis and rheumatism.

[71]  G R Burmester,et al.  Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? , 1997, Arthritis and rheumatism.

[72]  R. Thomas,et al.  Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. , 2000, Arthritis and rheumatism.

[73]  I. McInnes,et al.  The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis , 1996, Nature Medicine.

[74]  D. Woolley,et al.  Collagenase at sites of cartilage erosion in the rheumatoid joint. , 1977, Arthritis and rheumatism.

[75]  Malcolm D. Smith,et al.  Synovial mast cell responses during clinical improvement in early rheumatoid arthritis , 1998, Annals of the rheumatic diseases.

[76]  F. Epstein,et al.  Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.

[77]  D. Green,et al.  Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. , 2000, Immunology today.

[78]  I. McInnes,et al.  Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis , 1997, Nature Medicine.

[79]  G. Firestein,et al.  Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression. , 1994, Arthritis and rheumatism.

[80]  O. Johnell,et al.  Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment , 2000, Annals of the rheumatic diseases.

[81]  D. Woolley,et al.  Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes , 1999, Annals of the rheumatic diseases.

[82]  M. Burdick,et al.  Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. , 1992, The Journal of clinical investigation.

[83]  B. Bresnihan,et al.  Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. , 1989, British journal of rheumatology.

[84]  S. Ralston,et al.  Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. , 1994, Endocrinology.

[85]  Ian G. Charles,et al.  Induction of nitric oxide synthase in human chondrocytes. , 1993, Biochemical and biophysical research communications.

[86]  B. Bresnihan,et al.  Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. , 1996, British journal of rheumatology.

[87]  J. Case,et al.  Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. , 1989, The American journal of pathology.

[88]  G. Firestein,et al.  IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. , 1992, Journal of immunology.

[89]  E. Gravallese,et al.  Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. , 1995, Arthritis and rheumatism.

[90]  M. Walters.  Newly identified actions of the vitamin D endocrine system. , 1992, Endocrine reviews.

[91]  M. Feldmann,et al.  Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. , 1992, British journal of rheumatology.

[92]  A. Koch,et al.  Angiogenesis: Implications for rheumatoid arthritis , 1998 .

[93]  B. Dijkmans,et al.  Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. , 1998, British journal of rheumatology.

[94]  G. Firestein,et al.  Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[95]  A. Ladd,et al.  In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. , 1991, Arthritis and rheumatism.

[96]  B. Bresnihan,et al.  Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration , 1993, Clinical and experimental immunology.

[97]  R. N. Maini,et al.  Correlation of histopathological features of pannus with patterns of damage in different joints in rheumatoid arthritis. , 1991, Annals of the rheumatic diseases.

[98]  G. Firestein,et al.  Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. , 1997, The American journal of pathology.

[99]  P. Baeuerle,et al.  Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. , 1996, Arthritis and rheumatism.

[100]  J. Kirwan,et al.  The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. , 1995, The New England journal of medicine.

[101]  S. Goldring,et al.  Pathogenesis of bone erosions in rheumatoid arthritis , 2000, Current opinion in rheumatology.

[102]  R. Heller,et al.  Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes* , 1996, The Journal of Biological Chemistry.

[103]  R. Ochs,et al.  Chondrocyte apoptosis induced by nitric oxide. , 1995, The American journal of pathology.

[104]  D. Wernicke,et al.  Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. , 1996, The Journal of rheumatology.

[105]  S. Wallach,et al.  Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. , 1999, Arthritis and rheumatism.

[106]  F. Breedveld,et al.  Asymptomatic synovitis precedes clinically manifest arthritis. , 1998, Arthritis and rheumatism.

[107]  Y. Hirata,et al.  Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. , 1995, The Journal of clinical investigation.

[108]  F. Breedveld,et al.  Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. , 1997, Arthritis and rheumatism.

[109]  M. T. Walters,et al.  An investigation of the action of disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy. , 1987, Annals of the rheumatic diseases.

[110]  M. Weinblatt,et al.  The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. , 1993, Arthritis and rheumatism.

[111]  M. Frosch,et al.  Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. , 1999, The Journal of rheumatology.

[112]  Z Domljan,et al.  Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. , 1998, Arthritis and rheumatism.

[113]  Kraan,et al.  The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA) , 1999, Clinical and experimental immunology.

[114]  T. Rème,et al.  Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue , 1998, Clinical and experimental immunology.

[115]  J. Kirwan,et al.  Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. , 1998, British journal of rheumatology.

[116]  D. Hudig,et al.  Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. , 1993, Journal of immunology.

[117]  J. Dayer,et al.  IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. , 1992, Journal of immunology.

[118]  H. Schumacher,et al.  Synovitis of recent onset. A clinicopathologic study during the first month of disease. , 1972, Arthritis and rheumatism.

[119]  J. Kriegsmann,et al.  Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[120]  C. Evans,et al.  Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture , 1994, FEBS letters.

[121]  G. Firestein,et al.  Signal transduction and transcription factors in rheumatic disease. , 1999, Arthritis and rheumatism.

[122]  M. Ziff,et al.  Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. , 1975, Arthritis and rheumatism.

[123]  G. Firestein,et al.  Apoptosis in rheumatoid arthritis synovium. , 1995, The Journal of clinical investigation.

[124]  H. Genant,et al.  A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. , 2000, Arthritis and rheumatism.

[125]  B. Bresnihan,et al.  Synovial tissue macrophages and joint erosion in rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.

[126]  D. Woolley,et al.  Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. , 1995, Annals of the rheumatic diseases.

[127]  B. Bresnihan,et al.  Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. , 1999, Rheumatology.

[128]  S. Ralston,et al.  Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. , 1997, British journal of rheumatology.

[129]  B. Bresnihan,et al.  Synovial tissue analysis in rheumatoid arthritis. , 1999, Bailliere's best practice & research. Clinical rheumatology.

[130]  F. Breedveld,et al.  Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. , 1999, Arthritis and rheumatism.

[131]  H. Moriya,et al.  Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody , 1999, Annals of the rheumatic diseases.

[132]  P. W. Johnston,et al.  Nitric oxide: A cytokine‐induced regulator of bone resorption , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[133]  M. Feldmann,et al.  Transforming growth factor‐β1 in rheumatoid synovial membrane and cartilage pannus junction , 1991, Clinical and experimental immunology.

[134]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[135]  F. Breedveld,et al.  Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. , 1997, Journal of immunology.

[136]  P. Petrow,et al.  Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. , 1998, The Journal of rheumatology.

[137]  A. Baldwin,et al.  NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[138]  F. Breedveld,et al.  Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. , 1994, Arthritis and rheumatism.

[139]  H. Menninger,et al.  Polymorphonuclear granulocytes at the pannus-cartilage junction in rheumatoid arthritis. , 1980, Arthritis and rheumatism.

[140]  H. Fassbender,et al.  Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. , 1983, Collagen and related research.

[141]  E. Seftor,et al.  Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. , 1998, The American journal of pathology.

[142]  J. Dayer,et al.  Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis , 1995 .

[143]  P. Lipsky,et al.  Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[144]  C. Debouck,et al.  Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts (*) , 1996, The Journal of Biological Chemistry.

[145]  M. Feldmann,et al.  Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[146]  F. Breedveld,et al.  Expression of adhesion molecules in early rheumatoid synovial tissue. , 1995, Clinical immunology and immunopathology.

[147]  M. Inaba,et al.  Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis. , 1997, Life sciences.

[148]  T. Sumida,et al.  Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes , 1997, Annals of the rheumatic diseases.

[149]  M. Lotz,et al.  The inducible production of nitric oxide by articular cell types. , 1994, Osteoarthritis and cartilage.

[150]  A. Koch,et al.  Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[151]  U. Müller-Ladner,et al.  Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. , 1996, The Journal of rheumatology.

[152]  J. Dayer,et al.  Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. , 1994, The Journal of biological chemistry.

[153]  K. Matsushima,et al.  Localisation of interleukin 8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. , 1994, Scandinavian journal of rheumatology.

[154]  M. Bayliss,et al.  The synovium-cartilage junction of the normal human knee. Implications for joint destruction and repair. , 2010, Arthritis and rheumatism.

[155]  S. Santavirta,et al.  Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[156]  H. P. McNeil,et al.  Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. , 1997, Arthritis and rheumatism.

[157]  J. Kriegsmann,et al.  A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. , 1994, Arthritis and rheumatism.

[158]  F. Breedveld,et al.  Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[159]  G. Burmester,et al.  Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. , 1998, Arthritis and rheumatism.

[160]  M. Feldmann,et al.  Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. , 1992, Arthritis and rheumatism.

[161]  R. Beckenbaugh,et al.  Tissue cytokine patterns distinguish variants of rheumatoid synovitis. , 1997, The American journal of pathology.

[162]  U. Andersson,et al.  Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.

[163]  J. V. van Meurs,et al.  Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. , 1999, Arthritis and rheumatism.

[164]  B. Bresnihan,et al.  Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[165]  A. Freemont,et al.  Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. , 1989, Annals of the rheumatic diseases.

[166]  Josef M. Penninger,et al.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.

[167]  M. Ahern,et al.  Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone. , 1996, Arthritis and rheumatism.

[168]  G. Alarcón,et al.  Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug. , 1999, The Journal of rheumatology.

[169]  G. Firestein.  Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? , 1996, Arthritis and rheumatism.